Treatment of dissociative symptoms with opioid antagonists: a systematic review (Abstract)

Treatment of dissociative symptoms with opioid antagonists: a systematic review Eur J Psychotraumatol 20 October 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591526/ Background: The clinical guidelines for the treatment of dissociation focus primarily on psychotherapy. However, different psychoactive drugs are used in clinical practice. The use of opioid antagonists has been proposed as a therapeutic option based on the theory […]

Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery? (Abstract)

Is Fibromyalgia a Fashionable Diagnosis or a Medical Mystery? Cureus 07 September 2023 https://pubmed.ncbi.nlm.nih.gov/37809234/ Despite its prevalence, there is no clear-cut diagnostic path or treatment paradigm for fibromyalgia; this can lead to a multiplicity of symptoms and comorbid conditions that complicate care. “Overlapping symptoms” describe conditions that can occur concomitantly with fibromyalgia and include migraine, […]

Patients’ Perspective, Quality of Life and Treatment Goals in Hailey-Hailey Disease… (Abstract)

Patients’ Perspective, Quality of Life and Treatment Goals in Hailey-Hailey Disease: lessons learned from the German National Registry J Eur Acad Dermatol Venereol 20 October 2023 https://pubmed.ncbi.nlm.nih.gov/37863661/ Background: Hailey-Hailey disease (HHD) remains a difficult-to-treat dermatosis and little is known about the patient’s perception of the disease activity, the treatment success, and its impact on quality-of-life […]

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19 (Abstract)

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19 Int Immunopharmacol 05 October 2023 https://pubmed.ncbi.nlm.nih.gov/37804660/ The global prevalence of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) stands at approximately 43 % among individuals who have previously had acute COVID-19. In contrast, in the United States, the National Center for Health Statistics (NCHS) estimates that […]

Complex Presentations, Identification and Treatment of Mast Cell Activation Syndrome… (Abstract)

Complex Presentations, Identification and Treatment of Mast Cell Activation Syndrome and Associated Conditions: A Case Report Integr Med (Encinitas) September 2023 https://pubmed.ncbi.nlm.nih.gov/37752934/ Mast Cell Activation Syndrome (MCAS) is only a recently recognized, multisystem disorder that has been historically underrecognized due its estimated high prevalence. Recognition, testing, and treatment all pose unique challenges to condition management. […]

Is low-dose naltrexone effective in chronic pain management? (Abstract)

Is low-dose naltrexone effective in chronic pain management? J Fam Pract September 2023 https://pubmed.ncbi.nlm.nih.gov/37729143/ YES. Low-dose naltrexone is as effective as amitriptyline in the treatment of painful diabetic neuropathy and has a superior safety profile (strength of recommendation [SOR], B; single randomized controlled trial [RCT]). Low-dose naltrexone significantly reduced pain by 32% in inflammatory conditions […]

Combination therapy: A New Tool for the Management of Obesity (Abstract)

Combination therapy: A New Tool for the Management of Obesity Endocr Metab Immune Disord Drug Targets 25 August 2023 https://pubmed.ncbi.nlm.nih.gov/37641995/ Obesity is a long-term lifestyle problem that can lead to disastrous consequences. Lifestyle interventions are one of the initial lines of management strategies for obesity but in long term, it is not very effective in […]

Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome… (Abstract)

Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome: A Case Series Cureus 13 August 2023 https://www.cureus.com/articles/176869-low-dose-naltrexone-use-in-postural-orthostatic-tachycardia-syndrome-a-case-series#!/ Introduction: In recent years, low-dose naltrexone has emerged as a novel off-label therapy for many chronic conditions including postural orthostatic tachycardia syndrome (POTS), however, there is little evidence for its efficacy. Methods: In this institutional review board (IRB)-approved case series, the […]

Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus (Abstract)

Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus Case Reports; JAAD Case Rep 19 June 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339115/ A rare subtype of epidermolysis bullosa, epidermolysis bullosa pruriginosa (EBP) is characterized by severely pruritic lichenified and hypertrophic prurigo-like nodules and plaques secondary to chronic itching. No standard first-line therapy currently exists. Reported is a case of […]

Ocular surface itch and pain: key differences and similarities between the two sensations (Abstract)

Ocular surface itch and pain: key differences and similarities between the two sensations Curr Opin Allergy Clin Immunol 25 July 2023 https://pubmed.ncbi.nlm.nih.gov/37490616/ Purpose of review: To review the pathophysiology and treatment of ocular itch and pain, encompassing nociceptive and neuropathic categories. Recent findings: Ocular itch and pain are sensations that arise from activation of ocular […]